NGL Fine-Chem vs Peers
- Market cap
- ₹1,811 crore
- P/E
- 22.5
- P/B
- 2.85
- ROE
- 14.5%
- Dividend yield
- 1.20%
- 52-week range
- ₹2,111.11 – ₹3,958.34
NGL Fine-Chem ranks 1st by market capitalisation among 1 Drug Manufacturers - General companies tracked by ATS. Its largest peers are NGL Fine-Chem. Its P/E of 22.5 compares with a peer median of 22.5.
NGL Fine-Chem vs Drug Manufacturers - General peers
Sorted by market capitalisation.
| Company | Close (₹) | 1D | Market cap (₹ cr) | P/E | P/B | ROE | 1Y return |
|---|---|---|---|---|---|---|---|
| NGL Fine-Chem | 2,932.10 | -2.23% | 1,811 | 22.5 | 2.85 | 14.5% | +18.5% |
| NGL Fine-Chem | 2,932.10 | -2.23% | 1,811 | 22.5 | 2.85 | 14.5% | +24.5% |
Source: NSE end-of-day prices; ratios from company filings. Data as of 9 October 2026. How this data is compiled.
NGL Fine-Chem peer comparison — frequently asked questions
Who are NGL Fine-Chem's competitors?
NGL Fine-Chem's listed peers in Drug Manufacturers - General include NGL Fine-Chem, ranked here by market capitalisation.
How does NGL Fine-Chem's P/E compare with its peers?
NGL Fine-Chem trades at a P/E of 22.5, against a median of 22.5 across the 1 Drug Manufacturers - General peers shown.
Which is the largest company among NGL Fine-Chem's peers?
By market capitalisation, the largest company in the group is NGL Fine-Chem at ₹1,811 crore, against ₹1,811 crore for NGL Fine-Chem.
Same Data For Peers
Trade NGL Fine-Chem With ATS
Track NGLFINE live and place orders from the Pocket app or the Pocket Web terminal with an ATS trading and demat account.
Figures are for information only and are not investment advice or a recommendation to buy, sell or hold any security. Investments in securities are subject to market risks; read all related documents carefully before investing.